Revenue

9 Months Ended

Mar. 31, 2025

Revenue

Revenue [Text Block]

Note 7. Revenue

As of March 31, 2025 and June 30, 2024, the net rebate liability was $222,215 and $263,959, respectively. The rebate liability is included in accrued expenses within the accompanying condensed consolidated balance sheets. As of March 31, 2025 and June 30, 2024, the allowance for sales discounts was $8,490 and $13,814, respectively. The allowance for sales discounts is included in trade accounts receivable, less allowance for credit losses in the accompanying condensed consolidated balance sheets.

The following table disaggregates revenue by major product category for the three and nine months ended March 31, 2025 and 2024, respectively:

		Three Months Ended March 31,				Nine Months Ended March 31,
		2025		2024		2025		2024
Physical Therapy and Rehabilitation Products	$	3,310,768	$	3,656,363	$	11,554,808	$	12,631,415
Orthopedic Soft Bracing Products		2,816,762		3,980,170		9,425,615		12,464,521
Other		23,986		21,313		73,566		65,175
	$	6,151,516	$	7,657,846	$	21,053,989	$	25,161,111